Clinico-social factors to choose radioactive iodine dose in differentiated thyroid cancer patients: an Asian survey

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Nuclear medicine communications

• Publication date

  2018-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MNM.0000000000000804PMID 29381585
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acknowledging gray areas: 2015 vs. 2009 American Thyroid Association differentiated thyroid cancer guidelines on ablating putatively low-intermediate-risk patients

  2017cited by this paper
• Patient release criteria following radioactive iodine-131 treatment in the light of international practice: where does South Africa fit in?

  2017cited by this paper
• American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer : The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

  2017cited by this paper
• The Impact of Metastatic Lymph Nodes on Risk Stratification in Differentiated Thyroid Cancer: Have We Reached a Higher Level of Understanding?

  2016cited by this paper
• Use of Evidence-Based Guidelines Reduces Radioactive Iodine Treatment in Patients with Low-Risk Differentiated Thyroid Cancer

  2015cited by this paper
• PRACTICAL BARRIERS TO IMPLEMENTATION OF THYROID CANCER GUIDELINES IN THE ASIA-PACIFIC REGION.

  2015cited by this paper
• The Impact of Socioeconomic Status on the Use of Adjuvant Radioactive Iodine for Papillary Thyroid Cancer

  2014cited by this paper
• The Asian Nuclear Medicine Board (ANMB); Why Do We Need It?

  2013cited by this paper
• History and Perspectives of AOFNMB

  2013cited by this paper
• Well‐differentiated thyroid carcinoma: The role of post‐operative radioactive iodine administration

  2013cited by this paper
• The utility of serum thyroglobulin measurement at the time of remnant ablation for predicting disease-free status in patients with differentiated thyroid cancer: a meta-analysis involving 3947 patients.

  2012cited by this paper
• Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2012cited by this paper
• Use of radioactive iodine for thyroid cancer.

  2011cited by this paper
• Application of post‐surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low‐risk papillary thyroid carcinoma

  2010cited by this paper
• Post-ablative serum thyroglobulin is an independent predictor of recurrence in low-risk differentiated thyroid carcinoma: a 16-year follow-up study.

  2010cited by this paper
• Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

  2009cited by this paper
• Why radioiodine remnant ablation is right for most patients with differentiated thyroid carcinoma

  2009cited by this paper
• 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

  2009cited by this paper
• Thyroglobulin measurement before rhTSH‐aided 131I ablation in detecting metastases from differentiated thyroid carcinoma

  2008cited by this paper
• Basis for physician recommendations for adjuvant radioiodine therapy in early-stage thyroid carcinoma: principal findings of the Canadian-American thyroid cancer survey.

  2008cited by this paper
• European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium.

  2006cited by this paper
• Well-Differentiated Epithelial Thyroid Cancer Management in the Asia Pacific Region: A Report and Clinical Practice Guideline

  2006cited by this paper
• Radioactive iodine therapy for malignant and benign thyroid disease: a Canadian national survey of physician practice

  2005cited by this paper
• Thyroglobulin assay 4 weeks after thyroidectomy predicts outcome in low-risk papillary thyroid carcinoma

  2005cited by this paper
• The British Thyroid Association guidelines for the management of thyroid cancer in adults

  2004cited by this paper
• Radionuclide therapy practice and facilities in Europe. EANM Radionuclide Therapy Committee.

  1999cited by this paper
• Diagnosis, treatment and follow-up of H.P.V.-C.I.N.

  1995cited by this paper
• Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.

  1994cited by this paper

• Correlation between socioeconomic indices and epidemiological indices of thyroid cancer from 1990 to 2019 year: a global ecologic study

  2024cites this paper
• Long-Term Survival Analysis and Prognostic Factors of Arabic Patients with Differentiated Thyroid Carcinoma: A 20-Year Observational Study at the King Hussein Cancer Center (KHCC) Involving 528 Patients

  2023cites this paper
• A long-term retrospective cohort-based risk-benefit analysis of augmenting total cumulative I-131 activity to 37GBq in differentiated thyroid cancer patients with skeletal metastases

  2023cites this paper
• Radioactive Iodine in Differentiated Carcinoma of Thyroid: An Overview.

  2023cites this paper
• Assessment of Different Radioiodine Doses for Post-ablation Therapy of Thyroid Remnants: A Systematic Review

  2022cites this paper
• The therapeutic responses to I-131 ablation in patients of differentiated thyroid carcinoma complicated with nodular goiter

  2022cites this paper
• Theranostics in the Arab World; Achievements & Challenges

  2022cites this paper
• Cancer diagnosis in areas of conflict

  2022cites this paper
• Clinical impact of radioactive iodine dose selection based on the number of metastatic lymph nodes in patients with papillary thyroid carcinoma: A multicenter retrospective cohort study

  2021cites this paper
• Clinical Significance and Potential Regulatory Mechanisms of Serum Response Factor in 1118 Cases of Thyroid Cancer Based on Gene Chip and RNA-Sequencing Data

  2020cites this paper
• Optimization of serum thyroglobulin measured at different time points for prognostic evaluation in differentiated thyroid carcinoma patients

  2020cites this paper
• Role of thyroglobulin in the management of patients with differentiated thyroid cancer

  2019cites this paper
• Comparison of I-131 Biokinetics after Recombinant Human TSH Stimulation and Thyroid Hormone Withdrawal Measured by External Detector in Patients with Differentiated Thyroid Cancer

  2019cites this paper
• The efficacy of radioactive iodine for the treatment of well-differentiated thyroid cancer with distant metastasis

  2018cites this paper
• 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

  2009cites this paper